psychminded.co.uk
News
 
home  
courses    
conferences    
archive/big issues    
comment    
books - new & used    
members forum    
discussion forum    
contact us    
advertise your jobs, courses and conferences    

New and second-hand psychology psychiatry and mental health books...


Have a story? Do you know of innovative practice? Get media coverage


Get email news updates at the members forum


Email a colleague
about this article

 

 


ADHD drug can increase risk of epileptic fits and abnormal heart rhythm, doctors told

February 20, 2006
by staff reporter

A drug prescribed to children diagnosed with attention deficit hyperactivity disorder (ADHD) is to carry a warning that it can increase the risk of epileptic fits and abnormal heart rhythm.

The drugs regulatory body, the Medicines and Healthcare Products Regulatory Agency (MHRA), has written to doctors with new advice on Strattera, prescribed last year to 15,000 patients.

The advice follows that of October last year when doctors were told that children on Strattera (atomoxetine) were at risk of having suicidal thoughts.

Since then the MHRA has led a Europe-wide review on the risks and benefits of Strattera.

The MHRA has told doctors that the drug, prescribed to children aged over six, is still beneficial.

Dr June Raine, the MHRA's director of medicines post-licensing, said, “We have written to health professionals to ensure that they are fully aware of the side effects of Strattera to allow them to make informed prescribing decisions.”

MHRA Stattera advice letter to doctors (pdf)


See also:
Feb 14, 2006: ADHD drugs should carry heart attack warning, US scientists recommend - pressure on UK’s drug licensers to issue similar warning likely to mount.
Mental health comment
Feb 14, 2006: Disordered thinking? - the prescribing of ADHD drugs is soaring, while concerns are escalating about dangerous side effects. Is it time the social and family lives of ADHD-diagnosed children are examined as much as their brains, asks Adam James
Jan 31, 2006: Prescribing of drugs to treat ADHD children doubled in six years - figures revealed by National Institute for Health and Clinical Excellence as it starts work on ADHD clinical guidelines
Oct 5, 2005: Watch out for suicidal behaviour for children on ADHD drug, regulator warns - new clinical trial data shows increased risk of suicidal tendencies in children on Strattera

Add your comments
What do you think? Email your comments on the above
article to the editor using the form below. Selected comments will be displayed.

First name:
Last name:
Current position:
Place of work:
E-mail address:
Story commenting upon: (type in article headline)
Comments: (you may find it easier to copy and paste from a word file)
 

© 2001-7  Psychminded Limited. All rights reserved

Email a colleague
about this article

 

 

 

 



Do you need a conference or events photographer?